Steven Madden, Ltd. SHOO reported first-quarter 2025 results, wherein the top line lagged the Zacks Consensus Estimate, while ...

Barring one-time items, adjusted earnings per share were 49 cents, topping the Zacks Consensus Estimate of 39 cents. Net ...

RXO (RXO) delivered earnings and revenue surprises of -50% and 4.74%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Uber TechnologiesUBER reported mixed first-quarter 2025 results, wherein earnings surpassed the Zacks Consensus Estimate but ...

Out of the 14 analysts that have coverage on BSE, 12 of them have a 'Buy' rating on the stock, while two others have a 'Hold' ...

MRF has also announced a final dividend of ₹229 per share for financial year 2025, which is the highest ever announced by the ...

After a round-trip for U.S. stocks following their tariff-fueled swoon, investors are wary of obstacles that will prevent the ...

Consolidated revenue was up 26 per cent to ₹2750 crore, operating profit grew 28 per cent to ₹360 crore while net profit rose ...

For its fiscal third quarter of 2025, Fabrinet's revenue rose by 19% year over year to $871.8 million. The story was a bit ...

Rosenblatt analyst Kevin Cassidy revised estimates for Navitas Semiconductor Corporation (NASDAQ:NVTS) following the first ...

EARNINGS FORECAST: Net profit is expected to fall to 318 million euros, according to the consensus. Infineon made a net profit of 394 million euros in the year-earlier period. Infineon's segment ...

Semaglutide--which is marketed as Wegovy for weight-loss and Ozempic for diabetes--is now no longer listed as being in short supply in the U.S. and the FDA has told anyone distributing copies of the ...